Global Health Security Capacity and Capability Measurement Framework Within the Biological Threat Reduction Program.

Nino Kharaishvili, Jane W Blake, Douglas H Gorsline, Lance R Brooks

Abstract read

In one paragraph

Article in Health security. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nino KharaishviliNino Kharaishvili, MD, MBA, is Director, Global Health Solutions, Jacobs, Arlington, VA. Jane W. Blake, MS, is Lead Associate, Global Defense Group, Booz Allen Hamilton, Lorton, VA. Douglas H. Gorsline, MA, is Division Chief for INDOPACOM, Biological Threat Reduction Program, Defense Threat Reduction Agency, Department of Defense, Fort Belvoir, VA. Lance R. Brooks is Chief, Wide Area and Infrastructure Decontamination Branch, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park. NC.

Jane W BlakeNino Kharaishvili, MD, MBA, is Director, Global Health Solutions, Jacobs, Arlington, VA. Jane W. Blake, MS, is Lead Associate, Global Defense Group, Booz Allen Hamilton, Lorton, VA. Douglas H. Gorsline, MA, is Division Chief for INDOPACOM, Biological Threat Reduction Program, Defense Threat Reduction Agency, Department of Defense, Fort Belvoir, VA. Lance R. Brooks is Chief, Wide Area and Infrastructure Decontamination Branch, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park. NC.

Douglas H GorslineNino Kharaishvili, MD, MBA, is Director, Global Health Solutions, Jacobs, Arlington, VA. Jane W. Blake, MS, is Lead Associate, Global Defense Group, Booz Allen Hamilton, Lorton, VA. Douglas H. Gorsline, MA, is Division Chief for INDOPACOM, Biological Threat Reduction Program, Defense Threat Reduction Agency, Department of Defense, Fort Belvoir, VA. Lance R. Brooks is Chief, Wide Area and Infrastructure Decontamination Branch, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park. NC.

Lance R BrooksNino Kharaishvili, MD, MBA, is Director, Global Health Solutions, Jacobs, Arlington, VA. Jane W. Blake, MS, is Lead Associate, Global Defense Group, Booz Allen Hamilton, Lorton, VA. Douglas H. Gorsline, MA, is Division Chief for INDOPACOM, Biological Threat Reduction Program, Defense Threat Reduction Agency, Department of Defense, Fort Belvoir, VA. Lance R. Brooks is Chief, Wide Area and Infrastructure Decontamination Branch, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park. NC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Biological Threat Reduction Program, part of the Nunn-Lugar Cooperative Threat Reduction Program since 1991, is mandated by the US Congress to regularly provide public reporting as part of its accountability. The Biological Threat Reduction Program recently designed a metrics and evaluation framework to measure its impact and effectiveness in partner countries. The framework focuses on capacity and capability strengthening related to biosafety, biosecurity, and biosurveillance. This is a marked shift from the previous approach, which relied on more tangible outcomes such as the elimination of weapons of mass destruction production assets, delivery devices, munitions, and construction activities. The new metrics and evaluation framework tracks the program's impact across 24 biosafety, biosecurity, and biosurveillance metrics and numerous capability, capacity, sustainability, and regional leadership indicators for human and animal health systems. The framework uses quantitative and qualitative inputs to generate measurement scores for program investment in partner countries. Overall, the framework provides a robust feedback loop between requirements, plans, and implementation processes throughout each step of the program's annual management lifecycle.

Indexed as

BiosurveillanceContainment of BiohazardsGlobal HealthAnimalsBioterrorismHumansPublic HealthSecurity MeasuresBiosafetyBiosecurityBiosurveillanceCapacity developmentInfectious diseasesProgram evaluationPublic health preparedness/response

Identifiers

PMID33784478

DOI10.1089/hs.2020.0023

PMCPMC8060709

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.